[The correlation of synuclein-γ and matrix metalloproteinase 9 in breast cancer]
- PMID: 24256593
[The correlation of synuclein-γ and matrix metalloproteinase 9 in breast cancer]
Abstract
Objectives: To evaluate the expression of synuclein-γ (SNCG) and metalloproteinase 9 (MMP-9) both in the invasive ductal breast cancer samples and T47D and T47D(SNCG)- cell lines, to investigate the correlation between SNCG and MMP-9.
Methods: Totally 96 invasive ductal breast cancer samples (female, mean age of (56 ± 8) years) were collected between June 2009 and June 2012. The expressions of SNCG and MMP-9 were investigated by immunohistochemistry. T47D and SNCG knock down T47D(SNCG)- cell lines were established and SNCG and MMP-9 protein expression were investigated by Western blot and gene expression by real-time PCR.
Results: Among 96 samples, 26 (27.1%) of them co-expressed SNCG and MMP-9, 30(31.2%) of them expressed neither SNCG nor MMP-9. The expression of SNCG was correlated with the expression of MMP-9 (r = 0.655, P = 0.000).SNCG mRNA level of T47D cell line was 13.5 fold of T47D(SNCG)- cell line and SNCG protein expression was 2.1 fold. While MMP-9 mRNA level of T47D cell line was 7.3 fold of T47D(SNCG)- cell line and MMP-9 protien expression was 1.6 fold.When SNCG was knocked down, the expression of MMP-9 decreased.
Conclusions: SNCG and MMP-9 are significantly correlated with each other in breast cancer. SNCG may promote the invasion and metastasis of breast cancer mediated by up-regulating the expression of MMP-9.
Similar articles
-
Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.Int J Cancer. 2007 Sep 15;121(6):1296-305. doi: 10.1002/ijc.22763. Int J Cancer. 2007. PMID: 17534899
-
Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells.Breast Cancer Res Treat. 2005 Nov;94(1):25-35. doi: 10.1007/s10549-005-6938-0. Breast Cancer Res Treat. 2005. PMID: 16142440
-
Stage-specific expression of breast cancer-specific gene gamma-synuclein.Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):920-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504205
-
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.Breast Cancer Res Treat. 2007 Mar;101(3):259-67. doi: 10.1007/s10549-006-9296-7. Epub 2006 Jul 4. Breast Cancer Res Treat. 2007. PMID: 16821081
-
Targeting synuclein-gamma to counteract drug resistance in cancer.Expert Opin Ther Targets. 2008 Jan;12(1):59-68. doi: 10.1517/14728222.12.1.59. Expert Opin Ther Targets. 2008. PMID: 18076370 Review.
Cited by
-
Synuclein Proteins in Cancer Development and Progression.Biomolecules. 2023 Jun 12;13(6):980. doi: 10.3390/biom13060980. Biomolecules. 2023. PMID: 37371560 Free PMC article. Review.
-
γ-Synuclein confers both pro-invasive and doxorubicin-mediated pro-apoptotic properties to the colon adenocarcinoma LS 174T cell line.Tumour Biol. 2015 Sep;36(10):7947-60. doi: 10.1007/s13277-015-3455-6. Epub 2015 May 9. Tumour Biol. 2015. PMID: 25956278
-
Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.J Exp Clin Cancer Res. 2018 Jun 15;37(1):117. doi: 10.1186/s13046-018-0783-6. J Exp Clin Cancer Res. 2018. PMID: 29903032 Free PMC article.
-
Unregulated long non-coding RNA-AK058003 promotes the proliferation, invasion and metastasis of breast cancer by regulating the expression levels of the γ-synuclein gene.Exp Ther Med. 2015 May;9(5):1727-1732. doi: 10.3892/etm.2015.2323. Epub 2015 Mar 2. Exp Ther Med. 2015. PMID: 26136884 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous